Cellceutix Corp  

(Public, OTCMKTS:CTIX)   Watch this stock  
Find more results for OTC:CTIX
1.28
+0.03 (2.41%)
Jul 29 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 1.23 - 1.28
52 week 0.94 - 2.79
Open 1.23
Vol / Avg. 59,607.00/139,808.00
Mkt cap 154.37M
P/E     -
Div/yield     -
EPS -0.11
Shares 122.54M
Beta 0.70
Inst. own 0%

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -128.30% -104.45%
Return on average equity -417.89% -319.44%
Employees 14 -
CDP Score - -

Address

100 Cummings Ctr Ste 151b
BEVERLY, MA 01915-6117
United States - Map
+1-978-6333623 (Phone)
+1-978-9216564 (Fax)

Website links

Description

Cellceutix Corporation is a clinical-stage pharmaceutical company. The Company is focused on developing and/or acquiring small molecule therapies. The Company's clinical programs include Kevetrin, Prurisol, Brilacidin and Brilacidin-OM. It is evaluating investigational drugs Kevetrin (thioureidobutyronitrile) for the treatment of cancers, Prurisol (KM-133) for the treatment of psoriasis, and Brilacidin for the treatment of skin infections and prevention of oral mucositis. The Company has also planned to conduct a Phase II clinical trial of topical host-defense proteins (HDP) mimic for the treatment of hidradenitis suppurativa (HS). It is also formulating and conducting pre-clinical experiments on topical Brilacidin for use in topical applications, such as diabetic foot ulcer infections, and for ear-related infections, such as otitis externa or draining otitis media. Other compounds owned by the Company are KM 391, KM 277, KM 278, KM 362, KM-3174 and KM-732.

Officers and directors

Krishna Menon Ph.D. Chairman of the Board, Chief Science Officer
Age: 68
Arthur P. Bertolino M.D. Ph.D. President, Chief Medical Officer
Age: 61
Leo Ehrlich CPA Chief Executive Officer, Chief Financial Officer, Director
Age: 57
Barry Alan Schechter M.D. Independent Director
Age: 51
Zorik Spektor M.D. Independent Director
Age: 58
Mark Robert Tobin Independent Director
Age: 42